Globus Medical, Inc.GMEDNYSE
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank36
5Y CAGR-20.4%
Year-over-Year Change
Year-over-year research & development expense growth
5Y CAGR
-20.4%/yr
Long-term compound
Percentile
P36
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 12.97% |
| 2024 | 32.05% |
| 2023 | 69.84% |
| 2022 | -24.99% |
| 2021 | 15.18% |
| 2020 | 40.69% |
| 2019 | 8.25% |
| 2018 | 27.05% |
| 2017 | -1.92% |
| 2016 | 22.64% |